Humanosphere: Op-ed: Is Global Health Industry Too Self-Serving In the Fight Against AIDS?

By Scott Barnhart and Joanna Diallo

Washington state’s global health community is a recognized leader in the fight against many diseases of poverty including HIV/AIDS. No question about that. The question is whether our region’s leadership, the way we choose to fight the pandemic, is actually doing more for us than the people we claim to be helping.

The Seattle Times: Population Health is a Moral Imperative — Here’s How We’ll Solve Local and Global Problems

By Ana Mari Cauce and Ali H. Mokdad

The Bill & Melinda Gates Foundation’s recent gift for construction of a population-health facility will greatly advance the interdisciplinary and collaborative work of our faculty members, students, partners and collaborators across the UW, the region and the world.

Stat: Congressional Funding for Zika is Welcome, but Not Enough to Protect Americans

By Kristina Adams Waldorf, Michael Gale Jr., and Lakshmi Rajagopal

Eight months after President Barack Obama requested emergency funding to support the US response to the Zika virus outbreak, Congress finally passed a $1.1 billion funding package. The funding, though welcome, is only about half of what the nation’s top health experts believe is needed to combat this new global health emergency.

...

Devex: The Future of Health Financing: Investing in Data

By Annie Haakenstad and Joseph Dieleman 

After more than a decade of immense growth, development assistance for health has flat lined. Development assistance for health (DAH) fueled a scale up of antiretrovirals, insecticide-treated bed nets, vaccinations and a host of important global health interventions. Over the same period, the spread of a number of infectious diseases was reversed, reducing premature death and disability across the developing world. The plateau in international funding may threaten to slow progress or even roll back these gains.

Reuters Africa: From Gene Editing to Death Traps, Seattle Scientists Innovate in Race to End Malaria

By Kieran Guilbert

When Kayode Ojo first fell sick with malaria as a young boy in Nigeria, his grandfather shunned modern medicine, venturing into the bush to search for herbs and plants to treat the disease.

Having succumbed to malaria a further 50 or more times in his life, the United States-based scientist, now in his forties, is determined that his research - to develop a drug to stop transmission from humans back to mosquitoes - will help to eradicate the deadly disease.

Pages